JP2010508253A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508253A5
JP2010508253A5 JP2009533884A JP2009533884A JP2010508253A5 JP 2010508253 A5 JP2010508253 A5 JP 2010508253A5 JP 2009533884 A JP2009533884 A JP 2009533884A JP 2009533884 A JP2009533884 A JP 2009533884A JP 2010508253 A5 JP2010508253 A5 JP 2010508253A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pyroglutamate
dimethylaminoethanol
oral route
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009533884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010508253A (ja
Filing date
Publication date
Priority claimed from FR0609548A external-priority patent/FR2907679B1/fr
Application filed filed Critical
Publication of JP2010508253A publication Critical patent/JP2010508253A/ja
Publication of JP2010508253A5 publication Critical patent/JP2010508253A5/ja
Withdrawn legal-status Critical Current

Links

JP2009533884A 2006-10-31 2007-10-31 軽度認知機能障害の治療に用いる唯一の薬剤としてのdmae Withdrawn JP2010508253A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609548A FR2907679B1 (fr) 2006-10-31 2006-10-31 Utilisation de dmae pour le traitement de deficit cognitif leger
PCT/EP2007/061737 WO2008053011A1 (fr) 2006-10-31 2007-10-31 Le dmae en tant qu'agent unique pour le traitement de deficit cognitif leger

Publications (2)

Publication Number Publication Date
JP2010508253A JP2010508253A (ja) 2010-03-18
JP2010508253A5 true JP2010508253A5 (https=) 2010-12-16

Family

ID=38050144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533884A Withdrawn JP2010508253A (ja) 2006-10-31 2007-10-31 軽度認知機能障害の治療に用いる唯一の薬剤としてのdmae

Country Status (18)

Country Link
US (1) US8207218B2 (https=)
EP (1) EP2083814B1 (https=)
JP (1) JP2010508253A (https=)
KR (1) KR20090082428A (https=)
CN (1) CN101528220A (https=)
AR (1) AR063764A1 (https=)
AU (1) AU2007316137A1 (https=)
BR (1) BRPI0718263A2 (https=)
CA (1) CA2667983A1 (https=)
FR (1) FR2907679B1 (https=)
IL (1) IL198463A0 (https=)
MA (1) MA30925B1 (https=)
MX (1) MX2009004682A (https=)
NO (1) NO20092099L (https=)
RU (1) RU2009120137A (https=)
TN (1) TN2009000159A1 (https=)
WO (1) WO2008053011A1 (https=)
ZA (1) ZA200903626B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157046A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for the mind

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002320251A1 (en) * 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Similar Documents

Publication Publication Date Title
US20240409514A1 (en) Methods for inhibiting native and promiscuous uptake of monoamine neurotransmitters
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
JP2009102342A5 (https=)
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
JP2004519469A5 (https=)
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
JP2015528471A5 (https=)
JP2010518122A5 (https=)
JP2012505883A5 (https=)
HRP20150644T1 (hr) Metoda za lijeäśenje atrijalne fibrilacije
UA85359C2 (ru) Таблетка, содержащая гранулированный материал с kmd-3213
JPH01268633A (ja) L−ドーパの直腸被吸収性形態
SE9901573D0 (sv) New compounds
JPWO2004066998A1 (ja) 安定な経口用固形医薬組成物
FI3706724T3 (fi) Suun kautta otettavia rifamysiini sv -koostumuksia
JP2006008707A (ja) 下痢型過敏性腸症候群治療剤
RU2009131745A (ru) Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2016505050A5 (https=)
JPH07504890A (ja) Nmda拮抗剤の相乗効果
JP2008540405A5 (https=)
JP2010508253A5 (https=)
WO2009100245A1 (en) Low dose hmg-coa reductase inhibitor with reduced side effects
JP2007512381A5 (https=)
JP2007534731A5 (https=)